Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neratinib + Paclitaxel in Solid Tumors and Breast Cancer
NCT00445458Phase 2Completed
- Sponsor
- Puma Biotechnology, Inc.
- Start
- Sep 2007
- Primary completion
- May 2011
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 9
01
Overview
A Phase 2 trial of neratinib in breast cancer, solid tumor, sponsored by Puma Biotechnology, Inc.. Started Sep 2007; status: completed.
02
Drugs
neratinib
03
Conditions
breast cancersolid tumor
Beyond the preview
Go deeper on NCT00445458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445458.